Table 2 Adherence to the treatment of hypothyroidism and association with other variables studied during pregnancy

Adherence to the treatment

306 (54.1%)

187 (32.9%)

74 (13.0%)

Adherence per year

p: 0.830

 2012

55 (64.7%)

17 (20.0%)

13 (15.3%)

 2013

60 (60.6%)

28 (28.3%)

11 (11.1%)

 2014

47 (58.8%)

24 (30.0%)

9 (11.2%)

 2015

39 (48.1%)

29 (35.8%)

13 (16.0%)

 2016

36 (40.4%)

44 (49.4%)

9 (10.1%)

 2017

36 (49.3%)

25 (34.2%)

12 (16.4%)

 2018

33 (55.0%)

20 (33.3%)

7 (11.7%)

Age of pregnant women (years)

32.8 ± 4.77

32.1 ± 5.64

30.7 ± 6.24

p: 0.007

Body mass index

24.8 (5.26%)

25.4 (5.29%)

24.4 (5,62%)

p: 0.311

Association with other variables

 Diabetes Mellitus

46 (62.2%)

21 (28.4%)

7(9.4%)

p: 0.301

 Arterial hypertension

10 (47.6%)

8 (38.1%)

3 (14.3%)

p: 0.774

 Dyslipidaemia

6 (66.7%)

2 (22.2%)

1 (11.1%)

p: 0.890

 Depression

12 (75.0%)

4 (25.0%)

0 (0.0%)

p: 0.195

 Preeclampsia

4 (66.7%)

2 (33.3%)

0 (0.0%)

p: 1.000

Duration of the pregnancy

p: 0.129

 Miscarriage

0 (0.0%)

0 (0.0%)

2 (100%)

 Preterm

22 (64.7%)

9 (26.5%)

3 (8.8%)

 Prolonged

7 (53.8%)

5 (38.5%)

1 (7.7%)

 At term

215 (52.5%)

143 (35.0%)

51 (12.5%)

 Caesarean delivery

56 (50.5%)

37 (33.3%)

18 (16.2%)

p: 0.493

Risk during pregnancy

p: 0.985

 Really high

12 (54.5%)

7 (31.8%)

3 (13.6%)

 High

135 (56.5%)

73 (30.5%)

31 (13.0%)

 Medium

53 (55.2%)

29 (30.2%)

14 (14.6%)

 No risk

82 (51.6%)

54 (34.0%)

23 (14.5%)